Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $540.48 ($5.2M) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $540.48 | 281 | $152K | 2.9% |
| 2 | $541.59 | 1,163 | $630K | 12.1% |
| 3 | $542.68 | 456 | $247K | 4.8% |
| 4 | $543.39 | 371 | $202K | 3.9% |
| 5 | $544.75 | 269 | $147K | 2.8% |
| 6 | $545.87 | 825 |
| $450K |
| 8.7% |
| 7 | $546.94 | 601 | $329K | 6.3% |
| 8 | $547.83 | 2,166 | $1.2M | 22.8% |
| 9 | $548.89 | 2,039 | $1.1M | 21.6% |
| 10 | $549.76 | 1,009 | $555K | 10.7% |
| 11 | $550.72 | 200 | $110K | 2.1% |
| 12 | $551.50 | 120 | $66K | 1.3% |
| Total | $546.65 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |